FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2806357551> ?p ?o ?g. }

• W2806357551 abstract "ABSTRACT Multidrug-resistant (MDR) tuberculosis, defined as tuberculosis resistant to the two first-line drugs isoniazid and rifampin, poses a serious problem for global tuberculosis control strategies. Lack of a safe and convenient model organism hampers progress in combating the spread of MDR strains of Mycobacterium tuberculosis . We reasoned that auxotrophic MDR mutants of M. tuberculosis would provide a safe means for studying MDR M. tuberculosis without the need for a biosafety level 3 (BSL3) laboratory. Two different sets of triple auxotrophic mutants of M. tuberculosis were generated, which were auxotrophic for the nutrients leucine, pantothenate, and arginine or for leucine, pantothenate, and methionine. These triple auxotrophic strains retained their acid-fastness, their ability to generate both a drug persistence phenotype and drug-resistant mutants, and their susceptibility to plaque-forming mycobacterial phages. MDR triple auxotrophic mutants were obtained in a two-step fashion, selecting first for solely isoniazid-resistant or rifampin-resistant mutants. Interestingly, selection for isoniazid-resistant mutants of the methionine auxotroph generated isolates with single point mutations in katG , which encodes an isoniazid-activating enzyme, whereas similar selection using the arginine auxotroph yielded isoniazid-resistant mutants with large deletions in the chromosomal region containing katG . These M. tuberculosis MDR strains were readily sterilized by second-line tuberculosis drugs and failed to kill immunocompromised mice. These strains provide attractive candidates for M. tuberculosis biology studies and drug screening outside the BSL3 facility. IMPORTANCE Elimination of Mycobacterium tuberculosis , the bacterium causing tuberculosis, requires enhanced understanding of its biology in order to identify new drugs against drug-susceptible and drug-resistant M. tuberculosis as well as uncovering novel pathways that lead to M. tuberculosis death. To circumvent the need for a biosafety level 3 (BSL3) laboratory when conducting research on M. tuberculosis , we have generated drug-susceptible and drug-resistant triple auxotrophic strains of M. tuberculosis suitable for use in a BSL2 laboratory. These strains originate from a double auxotrophic M. tuberculosis strain, H37Rv Δ panCD Δ leuCD , which was reclassified as a BSL2 strain based on its lack of lethality in immunocompromised and immunocompetent mice. A third auxotrophy (methionine or arginine) was introduced via deletion of metA or argB , respectively, since M. tuberculosis Δ metA and M. tuberculosis Δ argB are unable to survive amino acid auxotrophy and infect their host. The resulting triple auxotrophic M. tuberculosis strains retained characteristics of M. tuberculosis relevant for most types of investigations." @default.
• W2806357551 created "2018-06-13" @default.
• W2806357551 creator A5019123888 @default.
• W2806357551 creator A5024846490 @default.
• W2806357551 creator A5026128493 @default.
• W2806357551 creator A5029415745 @default.
• W2806357551 creator A5059137670 @default.
• W2806357551 creator A5064519786 @default.
• W2806357551 creator A5074827895 @default.
• W2806357551 creator A5087052691 @default.
• W2806357551 creator A5090225641 @default.
• W2806357551 date "2018-07-05" @default.
• W2806357551 modified "2023-10-16" @default.
• W2806357551 title "Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy" @default.
• W2806357551 cites W115625114 @default.
• W2806357551 cites W1643706003 @default.
• W2806357551 cites W1832123290 @default.
• W2806357551 cites W1899321525 @default.
• W2806357551 cites W1919468846 @default.
• W2806357551 cites W1934542416 @default.
• W2806357551 cites W1991801598 @default.
• W2806357551 cites W2024974612 @default.
• W2806357551 cites W2025395369 @default.
• W2806357551 cites W2028522909 @default.
• W2806357551 cites W2051506232 @default.
• W2806357551 cites W2058925610 @default.
• W2806357551 cites W2078663039 @default.
• W2806357551 cites W2086083146 @default.
• W2806357551 cites W2103230271 @default.
• W2806357551 cites W2106084243 @default.
• W2806357551 cites W2111184721 @default.
• W2806357551 cites W2114902148 @default.
• W2806357551 cites W2127639177 @default.
• W2806357551 cites W2137767020 @default.
• W2806357551 cites W2150938975 @default.
• W2806357551 cites W2159377027 @default.
• W2806357551 cites W2163380013 @default.
• W2806357551 cites W2170021421 @default.
• W2806357551 cites W2426895696 @default.
• W2806357551 cites W2537377728 @default.
• W2806357551 cites W2613849789 @default.
• W2806357551 doi "https://doi.org/10.1128/mbio.00938-18" @default.
• W2806357551 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5974470" @default.
• W2806357551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29844114" @default.
• W2806357551 hasPublicationYear "2018" @default.
• W2806357551 type Work @default.
• W2806357551 sameAs 2806357551 @default.
• W2806357551 citedByCount "27" @default.
• W2806357551 countsByYear W28063575512019 @default.
• W2806357551 countsByYear W28063575512020 @default.
• W2806357551 countsByYear W28063575512021 @default.
• W2806357551 countsByYear W28063575512022 @default.
• W2806357551 countsByYear W28063575512023 @default.
• W2806357551 crossrefType "journal-article" @default.
• W2806357551 hasAuthorship W2806357551A5019123888 @default.
• W2806357551 hasAuthorship W2806357551A5024846490 @default.
• W2806357551 hasAuthorship W2806357551A5026128493 @default.
• W2806357551 hasAuthorship W2806357551A5029415745 @default.
• W2806357551 hasAuthorship W2806357551A5059137670 @default.
• W2806357551 hasAuthorship W2806357551A5064519786 @default.
• W2806357551 hasAuthorship W2806357551A5074827895 @default.
• W2806357551 hasAuthorship W2806357551A5087052691 @default.
• W2806357551 hasAuthorship W2806357551A5090225641 @default.
• W2806357551 hasBestOaLocation W28063575511 @default.
• W2806357551 hasConcept C104317684 @default.
• W2806357551 hasConcept C114851261 @default.
• W2806357551 hasConcept C133936738 @default.
• W2806357551 hasConcept C142724271 @default.
• W2806357551 hasConcept C143065580 @default.
• W2806357551 hasConcept C20950039 @default.
• W2806357551 hasConcept C2776967927 @default.
• W2806357551 hasConcept C2777975735 @default.
• W2806357551 hasConcept C2781069245 @default.
• W2806357551 hasConcept C54355233 @default.
• W2806357551 hasConcept C71924100 @default.
• W2806357551 hasConcept C86803240 @default.
• W2806357551 hasConcept C89423630 @default.
• W2806357551 hasConceptScore W2806357551C104317684 @default.
• W2806357551 hasConceptScore W2806357551C114851261 @default.
• W2806357551 hasConceptScore W2806357551C133936738 @default.
• W2806357551 hasConceptScore W2806357551C142724271 @default.
• W2806357551 hasConceptScore W2806357551C143065580 @default.
• W2806357551 hasConceptScore W2806357551C20950039 @default.
• W2806357551 hasConceptScore W2806357551C2776967927 @default.
• W2806357551 hasConceptScore W2806357551C2777975735 @default.
• W2806357551 hasConceptScore W2806357551C2781069245 @default.
• W2806357551 hasConceptScore W2806357551C54355233 @default.
• W2806357551 hasConceptScore W2806357551C71924100 @default.
• W2806357551 hasConceptScore W2806357551C86803240 @default.
• W2806357551 hasConceptScore W2806357551C89423630 @default.
• W2806357551 hasFunder F4320307468 @default.
• W2806357551 hasFunder F4320310829 @default.
• W2806357551 hasFunder F4320337355 @default.
• W2806357551 hasIssue "3" @default.
• W2806357551 hasLocation W28063575511 @default.
• W2806357551 hasLocation W28063575512 @default.
• W2806357551 hasLocation W28063575513 @default.
• W2806357551 hasLocation W28063575514 @default.
• W2806357551 hasLocation W28063575515 @default.
• W2806357551 hasOpenAccess W2806357551 @default.

• next